|
C3ORF34 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77900999999148E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.84946999999269E-05 |
| Normal-vs-Stage2 |
1.554060E-04 |
| Normal-vs-Stage3 |
8.20169999999898E-05 |
| Normal-vs-Stage4 |
9.607700E-02 |
| Stage1-vs-Stage2 |
2.313800E-01 |
| Stage1-vs-Stage3 |
4.276600E-01 |
| Stage1-vs-Stage4 |
2.061700E-02 |
| Stage2-vs-Stage3 |
6.636200E-01 |
| Stage2-vs-Stage4 |
1.246220E-02 |
| Stage3-vs-Stage4 |
1.573630E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.83544999999841E-05 |
| Normal-vs-AfricanAmerican |
1.899580E-03 |
| Normal-vs-Asian |
4.728000E-01 |
| Caucasian-vs-AfricanAmerican |
4.934600E-01 |
| Caucasian-vs-Asian |
4.519200E-01 |
| AfricanAmerican-vs-Asian |
4.230600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.23299999999593E-05 |
| Normal-vs-Female |
2.026600E-04 |
| Male-vs-Female |
3.970600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.427600E-02 |
| Normal-vs-Age(41-60Yrs) |
1.758660E-03 |
| Normal-vs-Age(61-80Yrs) |
2.1045999999969E-05 |
| Normal-vs-Age(81-100Yrs) |
1.824620E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.436200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.318800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.828400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.655700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.439630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.212800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.087000E-01 |
| Normal-vs-Grade 2 |
1.8699999999594E-06 |
| Normal-vs-Grade 3 |
1.030050E-04 |
| Normal-vs-Grade 4 |
5.197900E-02 |
| Grade 1-vs-Grade 2 |
6.310800E-01 |
| Grade 1-vs-Grade 3 |
6.422600E-01 |
| Grade 1-vs-Grade 4 |
8.680200E-01 |
| Grade 2-vs-Grade 3 |
5.507000E-01 |
| Grade 2-vs-Grade 4 |
9.590000E-02 |
| Grade 3-vs-Grade 4 |
1.760780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.5837000000023E-05 |
| Normal-vs-ccB subtype |
2.760900E-04 |
| ccA subtype-vs-ccB subtype |
8.515600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.027000E-04 |
| Normal-vs-N1 |
9.186600E-01 |
| N0-vs-N1 |
3.946300E-02 |
|
|
